2021
Post-9/11 Veterans’ Heart Disease Knowledge, Self-Perceived Risk, and Prevention Beliefs and Behaviors
Gaffey AE, Haskell SG, Brandt CA, Bastian LA, Meadows JL, Burg MM. Post-9/11 Veterans’ Heart Disease Knowledge, Self-Perceived Risk, and Prevention Beliefs and Behaviors. Health Psychology 2021, 40: 737-746. PMID: 34780203, PMCID: PMC10691753, DOI: 10.1037/hea0001110.Peer-Reviewed Original ResearchConceptsSelf-perceived riskHeart diseasePrevention beliefsExact testHeart disease risk factorsPrevention behaviorsNontraditional factorsHeart disease awarenessDisease risk factorsHeart disease riskDisease-related knowledgeHeart disease knowledgeFisher's exact testMental health treatmentPost-9/11 veteransRisk factorsDisease awarenessDisease knowledgeWomen veteransPrevention strategiesHealth treatmentDisease riskGreater riskPersonalized approachDisease
2020
Evaluation of confounding in epidemiologic studies assessing alcohol consumption on the risk of ischemic heart disease
Wallach JD, Serghiou S, Chu L, Egilman AC, Vasiliou V, Ross JS, Ioannidis JPA. Evaluation of confounding in epidemiologic studies assessing alcohol consumption on the risk of ischemic heart disease. BMC Medical Research Methodology 2020, 20: 64. PMID: 32171256, PMCID: PMC7071725, DOI: 10.1186/s12874-020-0914-6.Peer-Reviewed Original ResearchConceptsIschemic heart disease riskHeart disease riskObservational studyImpact of alcoholPotential confoundersHeart diseaseDisease riskMultivariate modelIschemic heart diseaseResidual confoundingDisease relationshipsEpidemiologic studiesAlcohol consumptionConfoundersMultivariate analysisLack of consensusIndividual studiesStratification variablesDiseaseRiskSame exposureConfoundingDifferent studiesStudy findingsDifferent investigators
2019
Reclassification of coronary heart disease risk in a primary prevention setting: traditional risk factor assessment vs . coronary artery calcium scoring
Alashi A, Lang R, Seballos R, Feinleib S, Sukol R, Cho L, Schoenhagen P, Griffin BP, Flamm SD, Desai MY. Reclassification of coronary heart disease risk in a primary prevention setting: traditional risk factor assessment vs . coronary artery calcium scoring. Cardiovascular Diagnosis And Therapy 2019, 9: 214-220. PMID: 31275811, PMCID: PMC6603493, DOI: 10.21037/cdt.2019.04.05.Peer-Reviewed Original ResearchReynolds Risk ScoreC-reactive proteinCoronary heart disease riskHeart disease riskPrimary preventionCHD riskAsymptomatic middle-aged patientsAsymptomatic middle-aged subjectsAtherosclerotic cardiovascular disease (ASCVD) scoreTraditional risk factor assessmentDisease riskMean C-reactive proteinCoronary artery calcium scoringConsecutive asymptomatic subjectsSignificant risk reclassificationCoronary artery calcificationMiddle-aged patientsRisk factor assessmentMiddle-aged subjectsStandard risk factorsASCVD scorePrevention clinicArtery calcificationCAC scoringAsymptomatic subjects
2018
P622Reclassification of 10-year coronary heart disease risk in a primary prevention setting: traditional risk factor assessment vs. coronary artery calcium scoring
Alashi A, Lang R, Seballos R, Feinleib S, Sukol R, Cho L, Schoenhagen P, Griffin B, Flamm S, Desai M. P622Reclassification of 10-year coronary heart disease risk in a primary prevention setting: traditional risk factor assessment vs. coronary artery calcium scoring. European Heart Journal 2018, 39: ehy564.p622. DOI: 10.1093/eurheartj/ehy564.p622.Peer-Reviewed Original Research
2015
Sex Differences in Cardiac Risk Factors, Perceived Risk, and Health Care Provider Discussion of Risk and Risk Modification Among Young Patients With Acute Myocardial Infarction The VIRGO Study
Leifheit-Limson EC, D’Onofrio G, Daneshvar M, Geda M, Bueno H, Spertus JA, Krumholz HM, Lichtman JH. Sex Differences in Cardiac Risk Factors, Perceived Risk, and Health Care Provider Discussion of Risk and Risk Modification Among Young Patients With Acute Myocardial Infarction The VIRGO Study. Journal Of The American College Of Cardiology 2015, 66: 1949-1957. PMID: 26515996, PMCID: PMC4628727, DOI: 10.1016/j.jacc.2015.08.859.Peer-Reviewed Original ResearchConceptsCardiac risk factorsAcute myocardial infarctionHealth care provider discussionsRisk modificationRisk factorsHeart diseaseHealth care providersProvider discussionsVIRGO StudyYounger patientsMyocardial infarctionCare providersSignificant cardiac risk factorsYoung AMI patientsPatients age 18Heart disease riskRisk factor prevalenceSelf-perceived riskModified Poisson regressionSex differencesFactor prevalenceAMI patientsCardiac riskSpanish hospitalsProvider feedback
2011
The Risk of Incident Coronary Heart Disease Among Veterans With and Without HIV and Hepatitis C
Freiberg MS, Chang CC, Skanderson M, McGinnis K, Kuller LH, Kraemer KL, Rimland D, Goetz MB, Butt AA, Barradas M, Gibert C, Leaf D, Brown ST, Samet J, Kazis L, Bryant K, Justice AC. The Risk of Incident Coronary Heart Disease Among Veterans With and Without HIV and Hepatitis C. Circulation Cardiovascular Quality And Outcomes 2011, 4: 425-432. PMID: 21712519, PMCID: PMC3159506, DOI: 10.1161/circoutcomes.110.957415.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusHepatitis C virusHIV-HCVCensoring eventVeterans Aging Cohort Study Virtual CohortIncident coronary heart diseaseCoronary heart disease riskHeart disease riskCoronary heart diseaseHIV-1 RNARisk of CHDIncidence of CHDHCV statusVeteran EnrolleesAdjusted riskAntiretroviral therapyCD4 countCHD eventsHCV infectionHepatitis CCHD riskImmunodeficiency virusC virusHeart diseaseRisk factorsSex differences in endothelial function in the microvasculature: effects of PCOS
Stachenfeld N, Wenner M, Taylor H. Sex differences in endothelial function in the microvasculature: effects of PCOS. The FASEB Journal 2011, 25: 837.2-837.2. DOI: 10.1096/fasebj.25.1_supplement.837.2.Peer-Reviewed Original ResearchPolycystic ovary syndromeETB receptorsEffects of PCOSHeart disease riskLaser Doppler flowmetrySkin blood flowNormal reproductive functionDose-response curveEndothelial dysfunctionOvary syndromeVasoconstrictive responseVasodilatory responseEndothelial functionCutaneous microvasculatureETA receptorsHealthy womenAntagonist infusionDoppler flowmetrySmooth muscleBlood flowReceptor AReproductive functionDisease riskWomenReceptorsTiming and Duration of Menopausal Hormone Treatment May Affect Cardiovascular Outcomes
Harman SM, Vittinghoff E, Brinton EA, Budoff MJ, Cedars MI, Lobo RA, Merriam GR, Miller VM, Naftolin F, Pal L, Santoro N, Taylor HS, Black DM. Timing and Duration of Menopausal Hormone Treatment May Affect Cardiovascular Outcomes. The American Journal Of Medicine 2011, 124: 199-205. PMID: 21396500, PMCID: PMC3107840, DOI: 10.1016/j.amjmed.2010.09.021.Peer-Reviewed Original ResearchMeSH KeywordsBreast NeoplasmsCardiovascular SystemCoronary DiseaseDrug Administration ScheduleEstrogen Replacement TherapyEstrogensFemaleHumansMiddle AgedPostmenopausePrecision MedicineProgestinsRandomized Controlled Trials as TopicRisk AssessmentRisk FactorsThromboembolismTime FactorsWomen's HealthConceptsMenopausal hormone treatmentCoronary heart disease riskHeart disease riskHormone treatmentExcess coronary heart disease riskWomen's Health Initiative hormone trialsDisease riskBeneficial effectsEstrogen-alone trialCoronary heart diseaseYears of treatmentNet harmTreatment-related risksRoute of administrationCurrent FoodShort durationDrug Administration recommendationsDisease incidence ratesWHI dataWHI estrogenWHI findingsCardiovascular outcomesProgestin trialMenopausal symptomsRisk ratio
2004
Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts 1 2 3
Knekt P, Ritz J, Pereira MA, O'Reilly EJ, Augustsson K, Fraser GE, Goldbourt U, Heitmann BL, Hallmans G, Liu S, Pietinen P, Spiegelman D, Stevens J, Virtamo J, Willett WC, Rimm EB, Ascherio A. Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts 1 2 3. American Journal Of Clinical Nutrition 2004, 80: 1508-1520. PMID: 15585762, DOI: 10.1093/ajcn/80.6.1508.Peer-Reviewed Original ResearchConceptsCoronary heart diseaseSupplemental vitamin C intakeHighest intake quintileVitamin C intakeAntioxidant vitaminsIntake quintilesCHD incidenceCHD riskRelative riskVitamin ECHD eventsC intakeSupplemental vitamin E intakeVitamin C/dCoronary heart disease riskDietary confounding factorsLower CHD incidenceMajor CHD eventsVitamin CIncident CHD eventsHeart disease riskVitamin E intakeSupplemental vitamin CHigh vitamin ECohort studyPhysical activity and risk of coronary heart disease in India
Rastogi T, Vaz M, Spiegelman D, Reddy KS, Bharathi A, Stampfer MJ, Willett WC, Ascherio A. Physical activity and risk of coronary heart disease in India. International Journal Of Epidemiology 2004, 33: 759-767. PMID: 15044412, DOI: 10.1093/ije/dyh042.Peer-Reviewed Original ResearchConceptsLeisure-time exerciseCHD riskRisk factorsPhysical activityPhysical exerciseSedentary activitiesHospital-based case-control studyCoronary heart disease riskDisease riskHeart disease riskCoronary heart diseaseAcute myocardial infarctionRisk of CHDSex-adjusted analysesCase-control studyConditional logistic regressionPhysical inactivity levelsMultivariate adjustmentBrisk walkingMyocardial infarctionHeart diseaseRelative riskSedentary lifestyleElevated riskMultivariate analysisSex and Age Differences in Lipoprotein Subclasses Measured by Nuclear Magnetic Resonance Spectroscopy: The Framingham Study
Freedman D, Otvos J, Jeyarajah E, Shalaurova I, Cupples L, Parise H, D’Agostino R, Wilson P, Schaefer E. Sex and Age Differences in Lipoprotein Subclasses Measured by Nuclear Magnetic Resonance Spectroscopy: The Framingham Study. Clinical Chemistry 2004, 50: 1189-1200. PMID: 15107310, DOI: 10.1373/clinchem.2004.032763.Peer-Reviewed Original ResearchConceptsLipoprotein concentrationsCHD riskLipoprotein subclassesCoronary heart disease riskSex differencesLipoprotein particlesHeart disease riskFramingham Offspring StudyLipoprotein particle sizeLarge HDL particlesHDL particle sizeConcentration of triglyceridesSize of VLDLFrozen plasma samplesHDL cholesterolLDL cholesterolFramingham StudySubclass concentrationsSubclass profileLarge LDLOffspring StudyConcentration of lipidsHDL particlesMagnetic resonance spectroscopyFemale differencesPlasma Lipid and Lipoprotein Levels during the Follicular and Luteal Phases of the Menstrual Cycle
Barnett JB, Woods MN, Lamon-Fava S, Schaefer EJ, McNamara JR, Spiegelman D, Hertzmark E, Goldin B, Longcope C, Gorbach SL. Plasma Lipid and Lipoprotein Levels during the Follicular and Luteal Phases of the Menstrual Cycle. The Journal Of Clinical Endocrinology & Metabolism 2004, 89: 776-782. PMID: 14764796, DOI: 10.1210/jc.2003-030506.Peer-Reviewed Original ResearchConceptsMenstrual cycle phaseLuteal phasePremenopausal womenFollicular phaseMenstrual cycleTotal cholesterol/high-density lipoprotein cholesterolLow-density lipoprotein cholesterol levelsHigh-density lipoprotein cholesterolCoronary heart disease riskTotal cholesterol/HDLPremenopausal Caucasian womenLipoprotein cholesterol levelsHeart disease riskBody mass indexCholesterol/HDLLevels of LDLSex hormone levelsLevels of estradiolLipoprotein cholesterolLipoprotein levelsMass indexEstrogen levelsLipoprotein profilePlasma lipidsCholesterol levels
2002
Evaluation and management of dyslipidemia in patients with HIV infection
Green ML. Evaluation and management of dyslipidemia in patients with HIV infection. Journal Of General Internal Medicine 2002, 17: 797-810. PMID: 12390557, PMCID: PMC1495116, DOI: 10.1046/j.1525-1497.2002.20201.x.Peer-Reviewed Original ResearchConceptsHIV infectionMetabolic abnormalitiesAntiretroviral therapyLipid abnormalitiesInsulin resistanceSevere hypertriglyceridemiaMultiple potential drug interactionsLong-term cardiovascular riskLow-density lipoprotein cholesterolCoronary heart disease riskNon-nucleoside reverse transcriptase inhibitorFrank diabetes mellitusPI-naïve patientsActive antiretroviral therapyCD4 lymphocyte countHIV infection statusHIV viral loadLipid-lowering medicationsManagement of dyslipidemiaElevated total cholesterolHeart disease riskPotential drug interactionsTreatment of dyslipidemiaReverse transcriptase inhibitorSame metabolic abnormality
1995
Cholesterol and Coronary Heart Disease Risk in Elderly Patients-Reply
Krumholz H, Seeman T, de Leon C, Vaccarino V, Berkman L. Cholesterol and Coronary Heart Disease Risk in Elderly Patients-Reply. JAMA 1995, 273: 1330-1331. DOI: 10.1001/jama.1995.03520410023011.Peer-Reviewed Original ResearchLow cholesterol levelsCholesterol levelsHealth statusCoronary heart disease riskHeart disease riskOverall health statusPoor health statusAssociation of cholesterolEarly mortalityAdverse outcomesFunctional statusElderly populationPsychosocial supportPotential associationDisease riskCognitive functionPatients' repliesSocioeconomic statusCholesterol groupSignificant differencesAfrican AmericansCholesterolOnly unique featureSubstantial numberStatus
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply